| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.0072 | 0.9 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.048 | 0.9 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.043 | 0.9 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.016 | 0.9 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |